Recombinant Human Integrin alpha 4 beta 7 Protein, CF

Newer Version Available: 11509-A3
Catalog # Availability Size / Price Qty
Best Seller
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (7)
Supplemental Products
Reviews (2)

Recombinant Human Integrin alpha 4 beta 7 Protein, CF Summary

Product Specifications

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Measured by the ability of the immobilized protein to support the adhesion of CHO Chinese hamster ovary cells transfected with VCAM-1. When 5 x 104 cells per well are added to Recombinant Human Integrin alpha 4/ beta 7/LPAM-1 coated plates (10 μg/mL, 100 μL/well), approximately
50-80% will adhere after 60 minutes at 37 °C.
Chinese Hamster Ovary cell line, CHO-derived human Integrin alpha 4 beta 7/LPAM-1 protein
Human Integrin alpha 4
(Tyr34-Gln970 (R591L & R878Q))
Accession # P13612
Acidic tail HHHHHH
Human Integrin beta 7
Accession # P26010
Basic tail
N-terminus C-terminus
N-terminal Sequence
Tyr34 (Integrin alpha 4) & Glu20 (Integrin beta 7)
Predicted Molecular Mass
112.8 kDa (Integrin alpha 4) & 84.7 kDa (Integrin beta 7)
130-155 kDa and 100-130 kDa, under reducing conditions.

Product Datasheets

You must select a language.



Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.


Formulation Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and MgCl2.
Reconstitution Reconstitute at 200 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Background: Integrin alpha 4 beta 7/LPAM-1

Integrin alpha 4 beta 7 is an integrin family adhesion receptor that shares subunits with alpha 4 beta 1 (VLA4) and the E-Cadherin receptor, alpha E beta 7 (1). It is a non-covalent heterodimer composed of two type I transmembrane glycoprotein subunits, a 150 kDa alpha 4 (CD49d) subunit and a 130 kDa beta 7 subunit (2, 3). The alpha 4 extracellular domain (ECD) contains an N-terminal beta -propeller structure followed by thigh, calf-1, and calf-2 domains (1). The beta 7 ECD contains a vWFA domain, which interacts with the
alpha 4 beta -propeller to form a binding domain. Metal ion binding sites termed MIDAS and LIMBS promote firm adhesion, and another site termed ADMIDAS is a negative regulatory site that promotes rolling (4-6). The human alpha 4 ECD shares 85% amino acid sequence identity with the mouse, rat, and canine alpha 4 ECD. The human beta 7 ECD shares 88% and 87% amino acid sequence identity with the rat and mouse beta 7 ECD, respectively. Integrin alpha 4 beta 7 binds the mucosal addressin MAdCAM-1, as well as VCAM-1 and Fibronectin (7). Integrin alpha 4 beta 7, which is critical for homing to intestinal mucosa, is induced during T cell activation in Peyer’s patches or mesenteric lymph nodes (8, 9). Its expression requires signals from local dendritic and stromal cells, including secreted retinoic acid (10, 11). The HIV-1 envelope protein gp120 binds to the active form of Integrin alpha 4 beta 7, and this may or may not account for the concentration of HIV-1 virus in the gut-associated lymphoid tissue (GALT) (12-14). Integrin  alpha 4 beta 7 may also be involved in lymphocyte trafficking in acute intestinal graft vs. host disease (GVHD) (15).

  1. Luo, B.H. et al. (2007) Annu. Rev. Immunol. 25:619.
  2. Takada, Y. et al. (1989) EMBO J. 8:1361.
  3. Erle, D.J. et al. (1991) J. Biol. Chem. 266:11009.
  4. Chen, J. et al. (2004) J. Biol. Chem. 279:55556.
  5. Park, E.J. et al. (2007) J. Clin. Invest. 117:2526.
  6. Yu, Y. et al. (2012) J. Cell Biol. 196:131.
  7. Yang, Y. et al. (1998) Eur. J. Immunol. 28:995.
  8. Wagner, N. et al. (1996) Nature 382:366.
  9. Johansson-Lindbom, B. and W.W. Agace (2007) Immunol. Rev. 215:226.
  10. Hammerschmidt, S.I. et al. (2008) J. Exp. Med. 205:2483.
  11. Edele, F. et al. (2008) J. Immunol. 181:3745.
  12. Arthos, J. et al. (2008) Nat. Immunol. 9:301.
  13. Cicala, C. et al. (2009) Proc. Natl. Acad. Sci. USA 106:20877.
  14. Monteiro, P. et al. (2011) J. Immunol. 186:4618.
  15. Chen, Y.B. et al. (2013) Bone Marrow Transplant. 48:598.
Entrez Gene IDs
3676 (Human); 16402 (Mouse)
Alternate Names
269C wild type; CD49 antigen-like family member D; CD49d antigen; CD49d; CD49d/beta7; CD49Dantigen CD49D, alpha-4 subunit of VLA-4 receptor; IA4; Integrin alpha 4 beta 7; integrin alpha 4; integrin alpha-4 subunit; integrin alpha-4; Integrin alpha-IV; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); LPAM1; LPAM-1; MGC90518; very late activation protein 4 receptor, alpha 4 subunit; VLA-4 subunit alpha

Citations for Recombinant Human Integrin alpha 4 beta 7 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

7 Citations: Showing 1 - 7
Filter your results:

Filter by:

  1. The Force-Dependent Mechanism of an Integrin ?4?7-MAdCAM-1 Interaction
    Authors: Su, Y;Luo, Z;Sun, D;Yang, B;Li, Q;
    International journal of molecular sciences
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  2. Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
    Authors: I Veisman, O Barzilay, L Bruckmayer, O Haj-Natour, U Kopylov, R Eliakim, S Ben-Horin, B Ungar
    Journal of Clinical Medicine, 2021-09-20;10(18):.
    Species: Human
    Sample Types: Serum
    Applications: ELISA Capture
  3. Irisin supports integrin-mediated cell adhesion of lymphocytes
    Authors: PK Myint, A Ito, MG Appiah, G Obeng, S Darkwah, E Kawamoto, A Gaowa, EJ Park, M Shimaoka
    Biochemistry and Biophysics Reports, 2021-03-08;26(0):100977.
    Species: Human
    Sample Types: Whole Cells
    Applications: ELISA Capture
  4. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
    Authors: D Karpova, MP Rettig, J Ritchey, D Cancilla, S Christ, L Gehrs, E Chendamara, MO Evbuomwan, M Holt, J Zhang, G Abou-Ezzi, H Celik, E Wiercinska, W Yang, F Gao, LG Eissenberg, RF Heier, SD Arnett, MJ Meyers, MJ Prinsen, DW Griggs, A Trumpp, PG Ruminski, DM Morrow, HB Bonig, DC Link, JF DiPersio
    J. Clin. Invest., 2019-05-14;129(7):2745-2759.
    Species: Human
    Sample Types: Protein
    Applications: Bioassay
  5. Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to ?4?7
    Authors: S Lertjuthap, C Cicala, D Van Ryk, M Liu, J Yolitz, D Wei, F Nawaz, A Doyle, B Horowitch, C Park, S Lu, Y Lou, S Wang, R Pan, X Jiang, F Villinger, SN Byrareddy, PJ Santangelo, L Morris, CK Wibmer, K Biris, RD Mason, J Gorman, J Hiatt, E Martinelli, M Roederer, D Fujikawa, G Gorini, G Franchini, A Arakelyan, AA Ansari, K Pattanapan, XP Kong, AS Fauci, J Arthos
    PLoS Pathog., 2018-08-28;14(8):e1007278.
    Species: Human
    Sample Types: Magnetic Nanoparticles, Recombinant Protein
    Applications: Bioassay, Surface Plasmon Resonance
  6. Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation
    Authors: JM Caldwell, MH Collins, KA Kemme, JD Sherrill, T Wen, M Rochman, EM Stucke, L Amin, H Tai, PE Putnam, MJ Jim‚nez-Da, MR Wormald, A Porollo, JP Abonia, ME Rothenberg
    Mucosal Immunol, 2017-01-04;0(0):.
    Species: Human, Mouse
    Sample Types: Recombinant Protein, Whole Cells
    Applications: Bioassay
  7. Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.
    Authors: Guerra-Perez N, Frank I, Veglia F, Aravantinou M, Goode D, Blanchard J, Gettie A, Robbiani M, Martinelli E
    J Immunol, 2015-01-26;194(5):2415-23.
    Species: Primate - Macaca mulatta (Rhesus Macaque)
    Sample Types: Whole Cells
    Applications: Bioassay


  1. What is the amino acid sequence of the acidic and basic tails?

    • Acidic and basic tails are added to the protein to help facilitate optimal activity. While we generally include sequence information on the product datasheet, the sequences of these tails are considered confidential information.

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Integrin alpha 4 beta 7 Protein, CF

Average Rating: 5 (Based on 2 Reviews)

5 Star
4 Star
3 Star
2 Star
1 Star

Have you used Recombinant Human Integrin alpha 4 beta 7 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:

Recombinant Human Integrin alpha 4 beta 7 Protein, CF
By Anonymous on 01/28/2022
Application: Cell Adhesion

Recombinant Human Integrin alpha 4 beta 7 Protein, CF
By Anonymous on 02/27/2018
Application: Binding assay/Protein-protein interaction